Stay updated on Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.

Latest updates to the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedNo substantive content changes detected on the Study Details page; updates appear to be UI/formatting adjustments without changes to core sections such as eligibility criteria or outcome measures — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoNo Change Detected
- Check42 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center (high importance). - Updated version to v3.2.0; removed v3.1.0 reference.SummaryDifference4%

- Check50 days agoChange DetectedUpdate the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.SummaryDifference0.1%

- Check64 days agoChange DetectedPage revision bumped from v3.0.1 to v3.0.2. The old revision tag and the 'Back to Top' element were removed as minor UI cleanup.SummaryDifference0.3%

- Check71 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.3%

- Check78 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, as well as the introduction of new MedlinePlus related topics on cancer. Notably, the previous topics on lung cancer have been removed.SummaryDifference5%

Stay in the know with updates to Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.